Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

NCT05972135 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Teclistamab
DRUG: Talquetamab
DRUG: Tocilizumab
DRUG: Oral Dexamethasone

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]